These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36030843)

  • 1. A Rheological Approach for Predicting Physical Stability of Amorphous Solid Dispersions.
    Song S; Wang C; Zhang B; Sun CC; Lodge TP; Siegel RA
    J Pharm Sci; 2023 Jan; 112(1):204-212. PubMed ID: 36030843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Variability of Physical Properties of Povidone K30 on Crystallization and Drug-Polymer Miscibility of Celecoxib-Povidone K30 Amorphous Solid Dispersions.
    Phadke C; Sharma J; Sharma K; Bansal AK
    Mol Pharm; 2019 Oct; 16(10):4139-4148. PubMed ID: 31454247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
    Xie T; Taylor LS
    J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of Amorphous Drugs by Polymers: The Role of Overlap Concentration (
    Sahoo A; Suryanarayanan R; Siegel RA
    Mol Pharm; 2020 Nov; 17(11):4401-4406. PubMed ID: 32975418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miscibility of Amorphous Solid Dispersions: A Rheological and Solid-State NMR Spectroscopy Study.
    Song S; Xu J; Chen Z; Sun CC; Munson EJ; Siegel RA
    J Pharm Sci; 2024 May; ():. PubMed ID: 38796157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T; Taylor LS
    Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs).
    Hu Z; Xu P; Ashour EA; Repka MA
    AAPS PharmSciTech; 2022 Jun; 23(6):169. PubMed ID: 35715519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions.
    Dalsania S; Sharma J; Munjal B; Bansal AK
    Pharm Res; 2018 Jan; 35(2):29. PubMed ID: 29368174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion.
    Knopp MM; Wendelboe J; Holm R; Rades T
    Eur J Pharm Biopharm; 2018 Sep; 130():290-295. PubMed ID: 30064702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
    Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL; Malekar SA; Cote C; Worthen DR
    Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions.
    Knopp MM; Nguyen JH; Becker C; Francke NM; Jørgensen EB; Holm P; Holm R; Mu H; Rades T; Langguth P
    Eur J Pharm Biopharm; 2016 Apr; 101():145-51. PubMed ID: 26899127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P; Puri V; Bansal AK
    Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility.
    Thakore SD; Akhtar J; Jain R; Paudel A; Bansal AK
    Mol Pharm; 2021 Aug; 18(8):2835-2866. PubMed ID: 34041914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the Correlation between Miscibility and Physical Stability of Amorphous Solid Dispersions Using Fluorescence-Based Techniques.
    Tian B; Tang X; Taylor LS
    Mol Pharm; 2016 Nov; 13(11):3988-4000. PubMed ID: 27700109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Implications of Drug-Polymer Interactions on the Physical Stability of Amorphous Solid Dispersions.
    Bookwala M; Wildfong PLD
    Pharm Res; 2023 Dec; 40(12):2963-2981. PubMed ID: 37389801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions.
    Ojo AT; Lee PI
    J Pharm Sci; 2021 Apr; 110(4):1495-1512. PubMed ID: 32818440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.